At Upstream Bio we strive to reach the source of inflammation and conquer it. We are leveraging our diverse roots and the team’s substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones.
Location: United States, Massachusetts, Waltham
Employees: 11-50
Total raised: $400M
Founded date: 2021
Investors 5
| Date | Name | Website |
| 28.06.2022 | Omega Fund... | omegafunds... |
| - | Access Bio... | accessbio-... |
| 06.06.2022 | OrbiMed | orbimed.co... |
| - | TCG Crosso... | tcgcrossov... |
| 26.08.2022 | HBM Partne... | hbmpartner... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.06.2023 | Series B | $200M | - |
| 12.06.2022 | Series A | $200M | OrbiMed |
Mentions in press and media 6
| Date | Title | Description | Source |
| 08.06.2023 | Upstream Bio Announces $200M Series B Financing | - | tcgcrossov... |
| 02.06.2022 | Upstream Bio Launches with $200M Series A | - | tcgcrossov... |
| 02.06.2022 | Upstream Bio Raises $200M in Series A Financing | Upstream Bio, a Waltham, Mass.-based biotech company focused on inflammation, raised $200 million in... | finsmes.co... |
| - | Upstream Bio Announces $200M Series B Financing | - | tcgcrossov... |
| - | Upstream Bio Launches with $200M Series A | - | tcgcrossov... |
| - | Upstream Bio | “At Upstream Bio we strive to reach the source of inflammation and conquer it. We are leveraging our... | fastfounde... |